Agilent Technologies, Inc.: Form 10-Q for the period ended Jul 31, 2012
Filed with the SEC on Sep 5, 2012 and accepted by EDGAR at Sep 5, 2012, 17:30 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2012-07-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2012-05-01 to 2012-07-31 | $1.72bn | us-gaap:SalesRevenueNet |
| Revenue | 9 months2011-11-01 to 2012-07-31 | $5.09bn | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2012-05-01 to 2012-07-31 | $833.0m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2011-11-01 to 2012-07-31 | $2.41bn | us-gaap:CostOfRevenue |
| Research and development | 3 months2012-05-01 to 2012-07-31 | $162.0m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2011-11-01 to 2012-07-31 | $490.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2012-05-01 to 2012-07-31 | $458.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2011-11-01 to 2012-07-31 | $1.35bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2012-05-01 to 2012-07-31 | $270.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2011-11-01 to 2012-07-31 | $841.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2012-05-01 to 2012-07-31 | $24.0m | us-gaap:InterestExpense |
| Interest expense | 9 months2011-11-01 to 2012-07-31 | $75.0m | us-gaap:InterestExpense |
| Income tax | 3 months2012-05-01 to 2012-07-31 | −$5.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2011-11-01 to 2012-07-31 | $59.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2012-05-01 to 2012-07-31 | $243.0m | us-gaap:ProfitLoss |
| Net income | 9 months2011-11-01 to 2012-07-31 | $728.0m | us-gaap:ProfitLoss |
| Diluted EPS | 3 months2012-05-01 to 2012-07-31 | $0.69 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2011-11-01 to 2012-07-31 | $2.06 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2012-05-01 to 2012-07-31 | $0.70 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2011-11-01 to 2012-07-31 | $2.09 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2012-05-01 to 2012-07-31 | 353,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2011-11-01 to 2012-07-31 | 353,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2011-11-01 to 2012-07-31 | $743.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2011-11-01 to 2012-07-31 | $132.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2012-05-01 to 2012-07-31 | $35.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Dividends paid | 9 months2011-11-01 to 2012-07-31 | $70.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 9 months2011-11-01 to 2012-07-31 | $78.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2012-07-31 | $1.92bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2012-07-31 | $4.21bn | us-gaap:AssetsCurrent |
| Total assets | At period end2012-07-31 | $9.76bn | us-gaap:Assets |
| Current liabilities | At period end2012-07-31 | $2.09bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2012-07-31 | $4.88bn | us-gaap:Liabilities |
| Long-term debt | At period end2012-07-31 | $1.71bn | us-gaap:LongTermDebtNoncurrent |
| Short-term borrowings | At period end2012-07-31 | $500.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2012-07-31 | $4.87bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2012-07-31 | 348,443,140 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001090872-12-000006. Last ingested by Listed: Oct 24, 2026, 15:02 ET. Listed shows no prices and gives no investment advice.